Hyaluronan, CD44 and its variant exons in human trophoblast invasion and placental angiogenesis.
Both hyaluronan and one of its receptors, CD44, can be demonstrated in the early human conceptus and in placental stroma. The variants of CD44 resulting from variable exon splicing are found in metastasizing human malignancies and are also involved in hyaluronan uptake and degradation. The resulting hyaluronan fragments are known to be highly angiogenic. We postulated that the self-limited process of trophoblast invasion of the uterine decidua results in part from the strategy of alternative splicing of CD44, similar to that used by invasive cancer cells in the course of metastatic spread and possibly angiogenesis. Monoclonal antibodies specific for CD44s and for an exon expressed during metastatic tumour progression, CD44v7, were used to examine this hypothesis. In this study we found human trophoblasts, for the first time, to express CD44. Intermediate trophoblasts of first and second trimester exhibited the standard form of CD44 while extravillous trophoblasts, which are responsible for the invading characteristics of the placenta, were positive for the alternatively spliced form, the CD44v7-8. Moreover, in the case of placenta accreta there was a prominent membrane staining of the trophoblasts that were embedded in the fibrin layer over the myometrium. The highly metastatic choriocarcinoma cells also expressed CD44v7-8. We propose, therefore, that the invading trophoblasts utilize the alternatively splicing machinery. These cells retain their invasive capabilities through the permissive ECM by carrying the CD44v7-8 isoform, which binds weakly to hyaluronan and thus prevents it from being degraded by intracellular hyaluronidase.
Goshen
R
R
Department of Biological Chemistry, Silberman Institute of Life Sciences, Hebrew University, Jerusalem, Israel.
Ariel
I
I
Shuster
S
S
Hochberg
A
A
Vlodavsky
I
I
de Groot
N
N
Ben-Rafael
Z
Z
Stern
R
R
D017398:Alternative Splicing; D002822:Choriocarcinoma / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D004717:Endometrium / Q000276:immunology / Q000378:metabolism; D005091:Exons; D005260:Female; D014644:Genetic Variation; D006801:Humans; D018960:Hyaluronan Receptors / Q000235:genetics* / Q000378:metabolism*; D006820:Hyaluronic Acid / Q000378:metabolism*; D006828:Hydatidiform Mole / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D009215:Myometrium / Q000276:immunology / Q000378:metabolism; D018919:Neovascularization, Physiologic; D010920:Placenta / Q000098:blood supply* / Q000276:immunology / Q000378:metabolism; D010921:Placenta Accreta / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D011247:Pregnancy; D014327:Trophoblasts / Q000276:immunology / Q000378:metabolism*; D014594:Uterine Neoplasms / Q000235:genetics / Q000276:immunology / Q000378:metabolism
D018960:Hyaluronan Receptors; D006820:Hyaluronic Acid